首页> 外文期刊>Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation >Killer Immunoglobulin-like Receptor (KIR) Genotypes Influences NK Cells' Response to Epstein - Barr Virus and the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic HCT

【24h】

Killer Immunoglobulin-like Receptor (KIR) Genotypes Influences NK Cells' Response to Epstein - Barr Virus and the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic HCT

机译：杀伤性免疫球蛋白样受体（KIR）基因型影响同种异体HCT后NK细胞对爱泼斯坦-巴尔病毒的反应以及发生移植后淋巴增生性疾病（PTLD）的风险

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation》 |2015年第1期|共2页
作者
Faridi Rehan Mujeeb; Kemp Taylor J.; Dharmani Poonam; Lewis Victor; Berka Noureddine; Storek Jan; Khan Faisal;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词
入库时间 2022-08-18 09:02:09

相似文献

外文文献
中文文献
专利

1. Killer Immunoglobulin-like Receptor (KIR) Genotypes Influences NK Cells' Response to Epstein - Barr Virus and the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic HCT [J] . Faridi Rehan Mujeeb, Kemp Taylor J., Dharmani Poonam, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：杀伤性免疫球蛋白样受体（KIR）基因型影响同种异体HCT后NK细胞对爱泼斯坦-巴尔病毒的反应以及发生移植后淋巴增生性疾病（PTLD）的风险
2. PHENOTYPIC AND FUNCTIONAL EVALUATION OF KIR-REGULATED NATURAL KILLER CELLS RESPONDING TO EPSTEIN - BARR VIRUS: IMPLICATIONS ON POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) AFTER ALLOGENEIC HCT. [J] . Faridi Rehan M., Manocha Amit, Dharmani Poonam, Human Immunology: Official Journal of the American Society for Histocompatibility and Immunogenetics . 2017,第Suppla1期

机译：对Epstein - Barr病毒反应的KIR调节的自然杀伤细胞的表型和功能评估：对同种异体HCT后移植后淋巴抑制性疾病（PTLD）的影响。
3. PHENOTYPIC AND FUNCTIONAL EVALUATION OF KIR-REGULATED NATURAL KILLER CELLS RESPONDING TO EPSTEIN - BARR VIRUS: IMPLICATIONS ON POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) AFTER ALLOGENEIC HCT. [J] . Faridi Rehan M., Manocha Amit, Dharmani Poonam, Human Immunology: Official Journal of the American Society for Histocompatibility and Immunogenetics . 2017,第Suppla1期

机译：对Epstein - Barr病毒反应的KIR调节的自然杀伤细胞的表型和功能评估：对同种异体HCT后移植后淋巴抑制性疾病（PTLD）的影响。
4. Sequence-based genotyping of killer cell immunoglobulin-like receptors and their associations with HIV-1 resistance and disease progression. [D] . Hardie, Rae-Anne Michelle. 2009

机译：杀伤细胞免疫球蛋白样受体的基于序列的基因分型及其与HIV-1耐药性和疾病进展的关系。
5. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56dimNKG2A+KIR− NK Cells and Contributes to Suboptimal Control of EBV in Immunosuppressed Children With Post-transplant Lymphoproliferative Disorder [O] . Janice K. P. Lam, Tarik Azzi, K. F. Hui, 2020

机译：CytomeGalovirus和Epstein-Barr病毒的共感染CD56DIMNKG2A + KIR-NK细胞的频率降低并有助于移植后淋巴抑制性疾病的免疫抑制儿童中EBV的次优
6. Killer Immunoglobulin-like Receptor (KIR) Genotypes Influences NK Cells' Response to Epstein - Barr Virus and the Risk of Developing Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic HCT [O] . Faridi Rehan Mujeeb, Kemp Taylor J., Dharmani Poonam, 2015

机译：杀伤性免疫球蛋白样受体（KIR）基因型影响同种异体HCT后NK细胞对爱泼斯坦-巴尔病毒的反应以及发生移植后淋巴增生性疾病（PTLD）的风险

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号